Locations:
June 25, 2020/Cancer

The Future of Inguinal Lymph Node Dissection Is Robotic

A closer look at the innovative procedure

650×450-Inguinal-lymph-nodes_robotic-ports_20-URL-1830311

Penile cancer is rare — it accounts for less than 1% of cancers in men in the United States — but its burden is no less insidious. It begins at the penis and advanced cases tend to spread into the inguinal lymph nodes located either superficially or deep within the groin.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

An inguinal lymph node dissection, or lymphadenectomy, has been the standard of care to diagnose, treat and prevent the spread of penile cancer. The procedure has been associated with a high complication rate including flap necrosis and lymphedema. In response, urologists have worked to minimize complications. Greater efforts have been made to improve early detection and develop less invasive surgical techniques.

Jayram Krishnan, DO, MBA, a urologic oncologist in Cleveland Clinic’s Glickman Urological & Kidney Institute, advocates for a robotic approach to inguinal node dissection. “Anecdotally, we see a significant reduction in postoperative complication, paired with a faster recovery, enabling patients to return to their daily activities sooner,” he says.

Procedural details

Adherence is given to all principles of the open surgical approach, but the robot allows surgeons to utilize smaller incisions, sparing the saphenous vein and limiting the area of dissection to superior-medial to the saphenofemoral junction — not performing a sartorious flap. Thus, this technique mitigates many of the risks for wound and edema complications.

“We will follow these modifications during robotic resection of the inguinal nodes. Nodes, both superficial and deep, can be approached in this fashion and both sides can be performed safely during one setting,” he says. He notes that laparoscopic access is obtained with the use of a spacemaker balloon. Once space is created, the robotic ports are placed, as shown below. The robot is placed in a “side dock” configuration on each side.

Advertisement

A closer look of the inguinal lymph node dissection.

Once in the space, the classic “split and roll” technique is used with the robotic instruments. Anatomic landmarks are used to aid in the dissection. Multiple small, medium and large clips can be used through the assistant port for control of lymphatic channels and small vessels.

Alternatively, a robotic vessel sealer can be used. A multi-use laparoscopic bag is used to collect and retrieve lymph node packets as they are liberated from the region. Once the robot is undocked, careful attention is given to wrapping the thighs tightly to prevent postoperative lymphoceles. This can be transitioned to compression stockings in the future. Patients are instructed to ambulate within the first 24 hours.

Improving patient care

Dr. Krishnan has been incorporating this technique into his practice for the last six years, after completing an advanced urological robotic and laparoscopic fellowship training at Cleveland Clinic.

“Ultimately, our goal is to minimize pain and expedite recovery for patients. A robotic approach to inguinal node dissection has really contributed to these improved outcomes,” he says. “The future of this operation will, undoubtedly, be through the use of the robotic platform.”

Advertisement

Related Articles

AI tech
October 26, 2026/Cancer/Innovations

AI Task Force Develops Unified Strategy to Integrate Tech Innovations

Evaluating AI initiatives and their impact on operations and care delivery

DNA test
October 23, 2026/Cancer/News & Insight

Early Genetic Testing Linked to Bilateral Mastectomy in Young BRCA Carriers with Breast Cancer

Study reinforces the importance of genetic testing prior to local therapy decisions

Dr. Arun Singh
October 21, 2026/Cancer

Preserving Vision in Uveal Melanoma (Podcast)

Understanding expanding treatment options and potential advances

Patient and doctor
October 9, 2026/Cancer/News & Insight

First Radioligand Therapy Approved for Metastatic Hormone-Sensitive Prostate Cancer

Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%

Woman running
October 7, 2026/Cancer/Patient Support

Pilot Project Aids Cancer Survivors in Achieving Healthy Weight and Reducing Recurrent Risk

New program will help patients improve fitness and manage weight after cancer treatment

Dr Keith McCrae
October 6, 2026/Cancer/Benign Hematology

How is ITP Therapy Evolving?

Cleveland Clinic hematologist highlights new guidelines and treatment advances in immune thrombocytopenia

Bone metastasis
October 5, 2026/Cancer/Innovations

Digital Platform Cuts Bone Metastasis Treatment Decision Time

NIMBLE replaces weekly tumor board delays with same-day multidisciplinary recommendations

Prostate cancer
October 2, 2026/Cancer/Radiation Oncology

ArteraAI Prostate Biomarker Accurate Across Diverse Populations

Cleveland Clinic study provides validation for the test, which combines AI and pathological data to predict outcomes in postoperative patients

Ad